PL2932267T3 - Rozpoznawanie wiązania czynnego biologicznie środka z celem komórkowym z użyciem wewnątrzkomórkowego rezonansowego przeniesienia energii bioluminescencji - Google Patents

Rozpoznawanie wiązania czynnego biologicznie środka z celem komórkowym z użyciem wewnątrzkomórkowego rezonansowego przeniesienia energii bioluminescencji

Info

Publication number
PL2932267T3
PL2932267T3 PL13861977T PL13861977T PL2932267T3 PL 2932267 T3 PL2932267 T3 PL 2932267T3 PL 13861977 T PL13861977 T PL 13861977T PL 13861977 T PL13861977 T PL 13861977T PL 2932267 T3 PL2932267 T3 PL 2932267T3
Authority
PL
Poland
Prior art keywords
recognition
energy transfer
bioactive agent
target binding
resonance energy
Prior art date
Application number
PL13861977T
Other languages
English (en)
Polish (pl)
Inventor
Carolyn W. HITKO
Thomas Kirkland
Thomas Machleidt
Rachel F. OHANA
Matt ROBERS
Keith Wood
Original Assignee
Promega Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corporation filed Critical Promega Corporation
Publication of PL2932267T3 publication Critical patent/PL2932267T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/10Libraries containing peptides or polypeptides, or derivatives thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/60Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
PL13861977T 2012-12-12 2013-12-12 Rozpoznawanie wiązania czynnego biologicznie środka z celem komórkowym z użyciem wewnątrzkomórkowego rezonansowego przeniesienia energii bioluminescencji PL2932267T3 (pl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261736429P 2012-12-12 2012-12-12
US201361794461P 2013-03-15 2013-03-15
US201361880048P 2013-09-19 2013-09-19
EP13861977.0A EP2932267B1 (en) 2012-12-12 2013-12-12 Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
PCT/US2013/074765 WO2014093677A1 (en) 2012-12-12 2013-12-12 Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer

Publications (1)

Publication Number Publication Date
PL2932267T3 true PL2932267T3 (pl) 2020-10-19

Family

ID=50934963

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13861977T PL2932267T3 (pl) 2012-12-12 2013-12-12 Rozpoznawanie wiązania czynnego biologicznie środka z celem komórkowym z użyciem wewnątrzkomórkowego rezonansowego przeniesienia energii bioluminescencji

Country Status (13)

Country Link
US (1) US10024862B2 (enExample)
EP (2) EP3712154A1 (enExample)
JP (4) JP6751294B2 (enExample)
KR (2) KR102150479B1 (enExample)
CN (2) CN104871001B (enExample)
AU (1) AU2013359166B2 (enExample)
BR (1) BR112015013710B1 (enExample)
CA (2) CA3174484A1 (enExample)
DK (1) DK2932267T3 (enExample)
ES (1) ES2803503T3 (enExample)
PL (1) PL2932267T3 (enExample)
SG (1) SG11201504525VA (enExample)
WO (1) WO2014093677A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8524457B2 (en) 2009-09-22 2013-09-03 William Patterson Method for the selection of specific affinity binders by homogeneous noncompetitive assay
US10067149B2 (en) 2012-12-12 2018-09-04 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
US10024862B2 (en) * 2012-12-12 2018-07-17 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
ES2926463T3 (es) * 2013-03-15 2022-10-26 Promega Corp Activación de la bioluminiscencia mediante complementación estructural
CN104225611B (zh) * 2013-06-18 2017-06-30 天津键凯科技有限公司 达沙替尼与非线性构型聚乙二醇的结合物
US11365402B2 (en) 2014-09-12 2022-06-21 Promega Corporation Internal protein tags
EP3191601B1 (en) * 2014-09-12 2022-11-02 Promega Corporation Internal protein tags
WO2016127100A1 (en) * 2015-02-05 2016-08-11 Promega Corporation Luciferase-based thermal shift assays
EP3436037A4 (en) * 2016-03-31 2019-12-04 University of Southern California HIGHLY SENSITIVE AND SPECIFIC LUCIFERASE-BASED REPORTER TEST FOR ANTIGEN DETECTION
WO2017206041A1 (zh) * 2016-05-31 2017-12-07 王帅 测定细胞内配体靶蛋白相互作用持久力的方法
JP7200102B2 (ja) * 2016-11-01 2023-01-06 プロメガ コーポレイション エネルギー受容体に係留されたセレンテラジン類縁体
CN110226087A (zh) * 2017-01-27 2019-09-10 国立大学法人大阪大学 生物体物质的检测方法、该方法中使用的化学发光指示剂
EP3578978B1 (en) * 2017-02-03 2022-07-13 Osaka University Device and determination system using same
US11442063B2 (en) 2018-05-30 2022-09-13 Promega Corporation Broad spectrum kinase binding agents
WO2020041579A1 (en) 2018-08-23 2020-02-27 Promega Corporation Coelenterazine analogues
WO2020048607A1 (en) 2018-09-07 2020-03-12 Université Libre de Bruxelles Srsf2 as rna epigenetic factor
JP7703446B2 (ja) 2018-11-28 2025-07-07 プロメガ コーポレイション 反応性ペプチド標識付け
JP7584433B2 (ja) 2019-03-20 2024-11-15 プロメガ コーポレイション 光親和性プローブ
EP3953374A4 (en) * 2019-04-10 2023-06-07 Promega Corporation COMPOSITIONS AND METHODS FOR DETECTION OF ANALYTES USING BIOLUMINESCENCE
CN112147114B (zh) * 2019-06-27 2024-06-25 成都先导药物开发股份有限公司 一种利用荧光标记化合物确定化合物在活细胞中与靶标相互作用的方法
EP4073512B1 (en) 2019-12-10 2025-11-12 Promega Corporation Compositions and methods for bioluminescent detection using multifunctional probes
US20220064696A1 (en) * 2020-08-28 2022-03-03 Promega Corporation Target engagement assay for ras proteins
CN118703457A (zh) * 2021-04-01 2024-09-27 深圳华大生命科学研究院 一种刺虾荧光素酶Nluc的突变体及其应用
CN114394970B (zh) * 2022-01-05 2023-06-06 山东大学 一种酯类Furimazine衍生物及制备方法与应用
CN114813706B (zh) * 2022-06-29 2022-12-13 国科大杭州高等研究院 一种血细胞高光谱光镊捕获能量共振转移分析仪
JP2025536247A (ja) 2022-10-14 2025-11-05 プロメガ コーポレイション セレンテラジン類似体
CN116354927B (zh) * 2023-02-21 2025-02-07 杭州医学院 以烷烃或脂肪酸为连接链的hdac降解剂及其制备方法和应用
US20240368565A1 (en) * 2023-05-04 2024-11-07 Promega Corporation Complementation-based tags and reporters for dual-modality labeling
KR20250004513A (ko) 2023-06-29 2025-01-08 부산대학교 산학협력단 Bret-기반 rab11a 활성 바이오센서 및 이를 포함하는 세포주
CN117330755B (zh) * 2023-08-25 2024-03-26 广东省农业科学院农业生物基因研究中心 一种基于酶催化生物荧光定量检测dna-蛋白质相互作用的方法
KR102802452B1 (ko) 2023-11-07 2025-05-08 대한민국 LgBiT 단백질을 발현하는 세포주 및 HiBiT 단백질을 발현하는 구제역 바이러스를 이용한 구제역 바이러스 감염 여부 확인방법
US20250206747A1 (en) 2023-12-20 2025-06-26 Promega Corporation Coelenterazine analogues
CN119709661B (zh) * 2024-12-30 2025-10-10 佰翱得(无锡)新药开发有限公司 一种荧光素酶OLuc突变体及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928888A (en) * 1996-09-26 1999-07-27 Aurora Biosciences Corporation Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
CA2335305C (en) 1998-06-16 2006-05-23 Biosignal Packard Inc. A bioluminescence resonance energy transfer (bret) system and its use
ATE320000T1 (de) 1999-12-22 2006-03-15 Perkinelmer Biosignal Inc Ein biolumineszenz resonanz energie transfer (bret) system mit breitem spektralen resolution zwischen donator- und akzeptor-emission wellenlänge und ihre anwendung
WO2002029410A2 (en) 2000-10-06 2002-04-11 Quantum Dot Corporation Cells having a spectral signature, and methods of preparation and use thereof
DE10058091A1 (de) * 2000-11-23 2002-06-06 Bayer Ag Isolierte Luziferasen Lu164, LuAL und Lu22, sowie deren Verwendung
US20060099646A1 (en) * 2002-10-11 2006-05-11 Anders Heding Bret assay
GB0307559D0 (en) 2003-04-02 2003-05-07 Univ Nottingham Fluorescently tagged ligands
CN100473988C (zh) * 2004-07-08 2009-04-01 厦门大学 具有荧光共振能量转移特点的蛋白组合及其用途
WO2006086883A1 (en) * 2005-02-16 2006-08-24 Universite De Montreal Biosensors for monitoring receptor-mediated g-protein activation
GB0625678D0 (en) * 2006-12-21 2007-01-31 Lux Biotechnology Ltd Composition and method for detection of demineralisation
WO2008109463A2 (en) * 2007-03-02 2008-09-12 University Of Massachusetts Red-shifted luciferase
EP2006686A1 (en) * 2007-06-22 2008-12-24 Institut Pasteur Method for screening for selective modulator of the NF-kB pathway activation
EP2215227A2 (en) * 2007-11-05 2010-08-11 Promega Corporation Hybrid fusion reporter and uses thereof
US8962341B2 (en) * 2008-12-12 2015-02-24 The Commonwealth Medical College Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
KR101665352B1 (ko) 2009-05-01 2016-10-12 프로메가 코포레이션 광 출력이 향상된 합성 오플로포러스 루시퍼라제
US8263350B2 (en) * 2009-06-29 2012-09-11 The University Of Chicago Molecular affinity clamp technology and uses thereof
AU2011323418B2 (en) * 2010-11-02 2017-07-27 Promega Corporation Novel coelenterazine substrates and methods of use
EP2782916B1 (en) * 2011-11-21 2018-02-28 Promega Corporation Carboxy x rhodamine analogs
CN102798717B (zh) * 2012-06-15 2014-11-26 杭州师范大学 一种o6-甲基鸟嘌呤-dna甲基转移酶活性检测方法
US10067149B2 (en) 2012-12-12 2018-09-04 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
US10024862B2 (en) 2012-12-12 2018-07-17 Promega Corporation Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer

Also Published As

Publication number Publication date
KR102292431B1 (ko) 2021-08-20
JP2022078077A (ja) 2022-05-24
EP2932267A4 (en) 2016-06-22
CA3174484A1 (en) 2014-06-19
ES2803503T3 (es) 2021-01-27
JP7676487B2 (ja) 2025-05-14
JP2016500263A (ja) 2016-01-12
US20140194307A1 (en) 2014-07-10
EP2932267A1 (en) 2015-10-21
CN109612981A (zh) 2019-04-12
BR112015013710B1 (pt) 2022-08-09
AU2013359166A1 (en) 2015-07-09
JP7092691B2 (ja) 2022-06-28
WO2014093677A1 (en) 2014-06-19
JP6751294B2 (ja) 2020-09-02
KR20150094696A (ko) 2015-08-19
JP2023179413A (ja) 2023-12-19
KR102150479B1 (ko) 2020-09-01
AU2013359166B2 (en) 2019-09-19
JP7393451B2 (ja) 2023-12-06
CN104871001B (zh) 2018-09-11
BR112015013710A2 (pt) 2018-11-21
CA2894435A1 (en) 2014-06-19
JP2019071899A (ja) 2019-05-16
SG11201504525VA (en) 2015-07-30
CN104871001A (zh) 2015-08-26
EP2932267B1 (en) 2020-05-06
US10024862B2 (en) 2018-07-17
CN109612981B (zh) 2022-05-13
KR20200104928A (ko) 2020-09-04
EP3712154A1 (en) 2020-09-23
DK2932267T3 (da) 2020-07-20

Similar Documents

Publication Publication Date Title
SG11201504525VA (en) Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer
IL283883B (en) Mobile cellular communication system
GB201403466D0 (en) Phased-array transceiver
GB201201378D0 (en) Shared mobile wallet
EP2719057A4 (en) WIRELESS POWER TRANSFER FOR IMPLANTABLE DEVICES
EP3800765C0 (en) WIRELESS INDUCTIVE ENERGY TRANSFER
EP2807720A4 (en) WIRELESS ENERGY TRANSFER WITH REDUCED FIELDS
EP2715867A4 (en) ANTENNA CONTROL
GB201214655D0 (en) Antenna isolation using metamaterial
EP2787306A4 (en) ACCUMULATOR
GB201222625D0 (en) Improvements relating to tracking moving objects
EP2819243A4 (en) FRAME ANTENNA
GB201220203D0 (en) An antenna
PL2671043T3 (pl) Pocisk znakujący
GB2489611B (en) Small missile
IL228300A (en) Closed loop energy system
EP2489945C0 (de) Wärmespeicher
EP2728668A4 (en) ANTENNA
EP2678788A4 (en) INCREASE RESEARCH RESULTS
GB2495110B (en) Antenna combining
AU337413S (en) Piston
PL2530418T3 (pl) Zasobnik ciepła
PL2769002T3 (pl) Rurowy target
IL239214A0 (en) Detection of cellular target binding using a biologically active substance using resonance energy transfer of intracellular light-emitting biological substances
GB201109786D0 (en) RF distance finder